跳至主要内容
临床试验/NCT01378507
NCT01378507Unknown不适用

Endoscopic Submucosal Dissection for Gastrointestinal Neoplasms

Chinese PLA General Hospital1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2009年1月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
500
试验地点
1
主要终点
The lesion result before ESD

研究概览

简要总结

Endoscopic submucosal dissection (ESD) is a newly developed technique in the field of endoscopic treatment for GI neoplasms, because of its high rate of en bloc resection. The purpose of this study is to evaluate the efficacy and safety of ESD for GI neoplasms.

详细描述

Endoscopic mucosal resection (EMR) is widely accepted as a minimally invasive treatment for GI neoplasms.However, one disadvantage of EMR is that lesions larger than 2 cm in diameter must be removed in pieces, which may result in a high recurrence rate of residual tumor tissue. In addition, in most patients, pathological assessment cannot be conducted after the procedure. ESD can overcome the disadvantages of EMR. However, it is difficult to perform ESD for GI neoplasms because of the high rate of complications.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Submucosal tumor
  • Mucosal tumor (T1) in patients unsuitable for surgery

排除标准

  • Endoscopic ultrasound (EUS) or CT signs of metastasis
  • Insufficient access to tumor

结局指标

主要结局

The lesion result before ESD

时间窗: within 7 days before ESD

Including the location, morphology and size under endoscopy and narrow banding image of lesion.

Short-term result after ESD

时间窗: whithin 7 days after ESD

Including en bloc and curative resection rate, the specimen size, complications, lateral and vertical margin exposure of tumor, and lymphatic or vascular invasion.

次要结局

  • The safety of ESD procedure(3months, 6months, 1year, 2years, 3years, 4years and 5years after ESD)

研究者

发起方
Chinese PLA General Hospital
申办方类型
Other

研究点 (1)

Loading locations...

相似试验